- Home
- Publications
- Publication Search
- Publication Details
Title
Thymidine kinase 1 through the ages: a comprehensive review
Authors
Keywords
-
Journal
Cell and Bioscience
Volume 10, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-11-27
DOI
10.1186/s13578-020-00493-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Knockdown of Thymidine Kinase 1 Suppresses Cell Proliferation, Invasion, Migration, and Epithelial–Mesenchymal Transition in Thyroid Carcinoma Cells
- (2020) Chang Liu et al. Frontiers in Oncology
- Early prediction of pathologic response to neoadjuvant treatment of breast cancer: use of a cell-loss metric based on serum thymidine kinase 1 and tumour volume
- (2020) Bernhard Tribukait BMC CANCER
- Potential through simplicity: thymidine kinase-1 as a biomarker for CDK4/6 inhibitors
- (2020) Amelia McCartney et al. BRITISH JOURNAL OF CANCER
- Novel monoclonal antibodies against thymidine kinase 1 and their potential use for the immunotargeting of lung, breast and colon cancer cells
- (2020) Edwin J. Velazquez et al. Cancer Cell International
- Serial evaluation of serum thymidine kinase activity is prognostic in women with newly diagnosed metastatic breast cancer
- (2020) Anna-Maria Larsson et al. Scientific Reports
- Identification of hub genes in prostate cancer using robust rank aggregation and weighted gene co-expression network analysis
- (2019) Zhen-yu Song et al. Aging-US
- Prognostic role of serum thymidine kinase 1 activity in patients with hormone receptor–positive metastatic breast cancer: Analysis of the randomised phase III Evaluation of Faslodex versus Exemestane Clinical Trial (EFECT)
- (2019) Amelia McCartney et al. EUROPEAN JOURNAL OF CANCER
- Identification of important invasion and proliferation related genes in adrenocortical carcinoma
- (2019) Ali Mohamed Alshabi et al. MEDICAL ONCOLOGY
- Loss of thymidine kinase 1 inhibits lung cancer growth and metastatic attributes by reducing GDF15 expression
- (2019) Parmanand Malvi et al. PLoS Genetics
- Serological TK1 predict pre-cancer in routine health screenings of 56,178 people
- (2018) Yu Wang et al. Cancer Biomarkers
- The impact of mitotic errors on cell proliferation and tumorigenesis
- (2018) Michelle S. Levine et al. GENES & DEVELOPMENT
- Retrospective natural history of thymidine kinase 2 deficiency
- (2018) Caterina Garone et al. JOURNAL OF MEDICAL GENETICS
- Thymidine kinase 1 combined with CEA, CYFRA21-1 and NSE improved its diagnostic value for lung cancer
- (2018) Z.F. Jiang et al. LIFE SCIENCES
- Plasma thymidine kinase-1 activity predicts outcome in patients with hormone receptor positive and HER2 negative metastatic breast cancer treated with endocrine therapy
- (2018) Martina Bonechi et al. Oncotarget
- Clinical significance and diagnostic capacity of serum TK1, CEA, CA 19-9 and CA 72-4 levels in gastric and colorectal cancer patients
- (2018) Shufang Ning et al. Journal of Cancer
- Thymidine kinase 1 as a tumor biomarker: technical advances offer new potential to an old biomarker
- (2018) Kiran Kumar Jagarlamudi et al. Biomarkers in Medicine
- Thymidine kinase-1/CD31 double immunostaining for identifying activated tumor vessels
- (2018) S. Okamura et al. BIOTECHNIC & HISTOCHEMISTRY
- The Half-Life of Serum Thymidine Kinase 1 Concentration Is an Important Tool for Monitoring Surgical Response in Patients with Lung Cancer: A Meta-Analysis
- (2017) Xudan Lou et al. Genetic Testing and Molecular Biomarkers
- Thymidine kinase 1 expression in ovarian serous adenocarcinoma is superior to Ki-67: A new prognostic biomarker
- (2017) Jianjun Wang et al. TUMOR BIOLOGY
- Serum TK1 is a more reliable marker than CEA and AFP for cancer screening in a study of 56,286 people
- (2016) Yu Wang et al. Cancer Biomarkers
- Standardized Centile Curves and Reference Intervals of Serum Thymidine Kinase 1 Levels in a Normal Chinese Population Using the LMS Method
- (2016) Xia Cao et al. Genetic Testing and Molecular Biomarkers
- Thymidine Kinase Type 1 and C-Reactive Protein Concentrations in Dogs with Spontaneously Occurring Cancer
- (2016) K.A. Selting et al. JOURNAL OF VETERINARY INTERNAL MEDICINE
- A clinical evaluation of the TK 210 ELISA in sera from breast cancer patients demonstrates high sensitivity and specificity in all stages of disease
- (2016) J. Kiran Kumar et al. TUMOR BIOLOGY
- Validation of a network-based strategy for the optimization of combinatorial target selection in breast cancer therapy: siRNA knockdown of network targets in MDA-MB-231 cells as an in vitro model for inhibition of tumor development
- (2016) Tatiana M. Tilli et al. Oncotarget
- The p53-p21-DREAM-CDE/CHR pathway regulates G2/M cell cycle genes
- (2015) Martin Fischer et al. NUCLEIC ACIDS RESEARCH
- Components and regulation of nuclear transport processes
- (2014) Bastien Cautain et al. FEBS Journal
- Serum Thymidine Kinase 1 Activity in the Prognosis and Monitoring of Chemotherapy in Lung Cancer Patients: A Brief Report
- (2014) Benjamin Nisman et al. Journal of Thoracic Oncology
- Ki67 is a promising molecular target in the diagnosis of cancer (Review)
- (2014) LIAN TAO LI et al. Molecular Medicine Reports
- Comparison of diagnostic and prognostic performance of two assays measuring thymidine kinase 1 activity in serum of breast cancer patients
- (2012) Benjamin Nisman et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- Comparative active-site mutation study of human and Caenorhabditis elegans thymidine kinase 1
- (2012) Tine Skovgaard et al. FEBS Journal
- Elevation of serum thymidine kinase 1 in a bacterial infection: Canine pyometra
- (2012) H. Sharif et al. THERIOGENOLOGY
- Thymidine Kinase 1 Upregulation Is an Early Event in Breast Tumor Formation
- (2012) Melissa M. Alegre et al. Journal of Oncology
- Serological Thymidine Kinase 1 is a Biomarker for Early Detection of Tumours—A Health Screening Study on 35,365 People, Using a Sensitive Chemiluminescent Dot Blot Assay
- (2011) Zhi Heng Chen et al. SENSORS
- Elevated thymidine kinase 1 in serum following neoadjuvant chemotherapy predicts poor outcome for patients with locally advanced breast cancer
- (2011) ZHI-HENG HUANG et al. Experimental and Therapeutic Medicine
- Regulation and Functional Contribution of Thymidine Kinase 1 in Repair of DNA Damage
- (2010) Yen-Ling Chen et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Comparative aspects of the proliferation marker thymidine kinase 1 in human and canine tumour diseases
- (2010) H. von Euler et al. Veterinary and Comparative Oncology
- Thymidine kinase 1 expression defines an activated G1 state of the cell cycle as revealed with site-specific antibodies and ArrayScan™ assays
- (2009) Fabio Gasparri et al. EUROPEAN JOURNAL OF CELL BIOLOGY
- Metabolism, cell growth and the bacterial cell cycle
- (2009) Jue D. Wang et al. NATURE REVIEWS MICROBIOLOGY
- Elevated levels of thymidine kinase 1 peptide in serum from patients with breast cancer
- (2009) Lena Carlsson et al. UPSALA JOURNAL OF MEDICAL SCIENCES
- Characterization of Herpes Simplex Virus type 1 thymidine kinase mutants engineered for improved ganciclovir or acyclovir activity
- (2002) Mark S. Kokoris et al. PROTEIN SCIENCE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started